Medical Industry Feature

00:00:00

Vax Myths Unveiled: Navigating Flu Vaccine...

Medical Industry Feature ·

2024/01/23

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Wendy Wright, DNP Guest: Elias Chahine, PharmD, FCCP, FASCP While the flu may seem benign to some, it may result in up to 710,000 hospitalizations and up to 52,000 deaths every year.1 So how are current and concerning trends in declining flu vaccinations being addressed? To hear the latest updates and recommendations, join Dr. Charles Turck as he speaks with Dr. Wendy Wright, Owner and Family Nurse Practitioner at Wright &

en

00:00:00

The Importance of Pursuing Novel Treatments for Major...

Medical Industry Feature ·

2024/01/19

Guest: Aderonke Pederson, MD Major depressive disorder is a mental health condition that affects millions of Americans,1 and for the past several decades, treatment has consisted mainly of antidepressant therapy and psychotherapy.2,3 However, many patients still don't achieve their treatment goals and there are many potential barriers to accessing treatment. Learn more about these unmet needs in major depressive disorder care that underscore the importance of finding new treatment

en

00:00:00

Exploring the Use of Peptide-Based Formulas in...

Medical Industry Feature ·

2024/01/12

Host: Jennifer Caudle, DO Guest: Manpreet Mundi, MD Enteral nutrition intolerance is quite prevalent as it can be seen in up to 40 percent of patients who are tube fed. Due to the significant consequences of intolerance, there’s an urgency to manage patients symptoms, and one option that’s been shown to help is peptide-based tube feeding formulas. Joining Dr. Jennifer Caudle to talk about the management of enteral feeding intolerance with peptide-based tube feeding formulas is Dr

en

00:00:00

A Review of Kidney Biopsy in Complement-Mediated...

Medical Industry Feature ·

2024/01/03

Guest: Mark Haas, MD Kidney biopsy is the gold standard for the diagnosis of immunoglobin A (IgA) nephropathy and complement 3 glomerulopathy (C3G),1,2 and the accurate interpretation of kidney biopsy findings is important not only for diagnosis but also guiding clinical management of these conditions. Learn more about what the diagnostic process and findings for IgA nephropathy and C3G look like with Dr Mark Haas, a renal pathologist at Cedars-Sinai Medical Center in Los Angeles

en

00:00:00

The Four-Hit Model of IgA Nephropathy Pathogenesis

Medical Industry Feature ·

2024/01/03

Guest: Jai Radhakrishnan, MD The most widely accepted mechanism for the pathogenesis of immunoglobin A (IgA) nephropathy is referred to as the “four-hit model,” which is a sequence of four events that can occur.1-3 Here to break down each of those four stages is Dr. Jai Radhakrishnan, a nephrologist at Columbia University Medical Center in New York. References: Knoppova B, Reily C, King RG, et al. J Clin Med. 2021;10(19):4501. doi:10.3390/jcm10194501 Maillard N, Wyatt RJ, Julian BA,

en

00:00:00

The Complement System in the Pathogenesis of IgA...

Medical Industry Feature ·

2024/01/03

Guest: Richard Lafayette, MD, FACP Insights into the complement system are critical to our understanding of the pathogenesis of immunoglobin A (IgA) nephropathy.1 That’s why Dr. Richard Lafayette is here to share what we currently know about the complement system and its role in IgA nephropathy. Dr. Lafayette is a nephrologist at Stanford University Medical Center in California. References: Medjeral-Thomas NR, O'Shaughnessy MM. Adv Chronic Kidney Dis. 2020 Mar;27(2):111-119. doi:

en

00:00:00

Eureka for Influenza Prevention! Cell-Based Vaccines...

Medical Industry Feature ·

2023/12/04

Several factors impact vaccine effectiveness from year to year. One of them is the phenomenon of strain mismatch which may result from egg adaptation during the egg-based influenza vaccine manufacturing process.1 So what exactly is the process of egg-adaptation? Gather your esteemed colleagues from far and wide, and tune into this episode of World of Tomorrow to learn more. Reference: Rajaram S, Boikos C, Gelone DK, Gandhi A. Influenza vaccines: the potential benefits of cell-culture

en

00:00:00

The Interconnectivity of The Cardio-Renal-Metabolic...

Medical Industry Feature ·

2023/11/10

Guest: Pamela Kushner, MD, FAAFP The Cardio-Renal-Metabolic (CRM) systems are physiologically interconnected, and each one relies on energy homeostasis tofunction properly. So why is it important for clinicians to understand the CRM continuum to identify and assess comorbidities in order to effectively treat patients with heart failure? Dive into this episode with Dr. Pam Kushner, Clinical Professor at the University of California at Irvine, a Clinical Trialist, past Chair of the

en

00:00:00

The Disease Burden and Epidemiology of Heart Failure

Medical Industry Feature ·

2023/11/10

Guest: Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN Approximately 6.2 million adults in the US have heart failure (hf), and this number is projected to grow to more than 8 million by 2030. Knowing this alarming statistic, what do we need to know about the clinical characteristics of hf? Take a deep dive with Dr. Nancy Albert, associate chief nursing officer for the Office of Nursing Research and Innovation. Sponsored by Boehringer Ingelheim

en

00:00:00

Heart Failure Disease State Awareness

Medical Industry Feature ·

2023/11/10

Guest: Nancy M. Albert, PhD, CCNS, CHFN, CCRN, NE-BC, FAHA, FCCM, FHFSA, FAAN There are 4 stages of heart failure, ranging from being at risk for heart failure to having an advanced condition. So what key insights should we know about the ACC/AHA stages of heart failure and the NYHA heart failure functional classifications? Discover more with Dr. Nancy Albert, associate chief nursing officer for the Office of Nursing Research and Innovation. Sponsored by Boehringer Ingelheim

en

00:00:00

The Importance of Making an Accurate and Timely Heart...

Medical Industry Feature ·

2023/11/10

Guest: Pamela Kushner, MD, FAAFP Clinicians may agree that several challenges exist in diagnosing heart failure because patients may present with nonspecific symptoms or may have comorbidities. So what factors are important to evaluate when detecting and diagnosing heart failure in patients? Join Dr. Pam Kushner, clinical professor at the University of California at Irvine, as she walks us through the answer to this and more. Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc

en

00:00:00

Guideline Directed Medical Therapy for the Management...

Medical Industry Feature ·

2023/11/10

Guest: Stephen Greene, MD In 2022, the American Heart Association, American College of Cardiology, and Heart Failure Society of America created a joint guideline for the management of heart failure. Explore what the recommendations say and how they can help improve patient outcomes with Dr. Stephen Greene, an advanced heart failure specialist at Duke Heart Transplant Clinic and a cardiologist at Duke Cardiology Clinic in Durham, North Carolina. Sponsored by Boehringer Ingelheim

en

00:00:00

The Pathophysiology and Pathoetiology of Heart Failure

Medical Industry Feature ·

2023/11/10

Guest: Stephen Greene, MD One of the most important things we know about heart failure is that it doesn’t affect everyone equally, especially when you consider heart failure with reduced ejection fraction versus preserved ejection fraction. Dive into the complex pathophysiology and pathoetiology surrounding heart failure and how it differs when ejection fraction is reduced versus when it’s preserved with Dr. Stephen Greene, an advanced heart failure specialist at Duke Heart Transplant

en

00:00:00

A Treatment for NYHA Class II-III Obstructive HCM...

Medical Industry Feature ·

2023/11/07

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Amy Sehnert, MD With the FDA’s approval of CAMZYOS® (mavacamten), the first and only cardiac myosin inhibitor for symptomatic New York Heart Association (NYHA) class II-III adult patients, healthcare professionals and patients now have another treatment option that targets HCM at the source. Learn more about the clinical trial data that supported the FDA approval, and how healthcare professionals can prescribe CAMZYOS from Dr. Amy

en

00:00:00

The Dietary Management of Cow’s Milk Protein Allergy...

Medical Industry Feature ·

2023/10/31

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Kalpesh Thakkar, MD, MSCR Cow’s milk protein allergy is the most common food allergy in infants. And overall, it’s important to know that in general, the incidence of allergy is increasing worldwide. To take a deep dive, join Dr. Charles Turck as he speaks with Dr. Kalpesh Thakkar, Pediatric Gastroenterologist at Memorial Hermann Medical Group in Sugarland, Texas. All trademarks are owned by Société des Produits Nestlé S.A., Vevey,

en

00:00:00

Improving Tolerance with Blenderized Whole Food Tube...

Medical Industry Feature ·

2023/10/27

Host: Jennifer Caudle, DO Guest: Katherine Bennett, MPH, RD, CLEC Caregivers and children often face challenges when trying to find a formula that’s well-tolerated, and the burden of feeding intolerance extends to the healthcare system as well. Find out how blenderized whole food tube feeding whole food tube feeding formulas like Compleat Organic Blends can help address those challenges and benefit pediatric patients with Dr. Jennifer Caudle and Ms. Katherine Bennett, a registered

en

00:00:00

Integrating Multicancer Early Detection into Clinical...

Medical Industry Feature ·

2023/10/24

Host: Sana Raoof, MD, PhD Guest: Candace T. Westgate, DO, MPH, FACOG Guest: Mylynda Massart, MD, PhD The last five years have seen exciting progress with liquid biopsy tests, with one of them being a screening tool for multi-cancer early detection that looks for methylation patterns that can detect more cancers earlier, even before symptoms appear.1,2 Learn how you can incorporate this screening tool into clinical practice with Drs. Sana Raoof, Candace Westgate, and Mylynda

en

00:00:00

Cancer Screenings: The Impacts of Early Detection...

Medical Industry Feature ·

2023/10/24

Host: Jennifer Caudle, DO Guest: Sana Raoof, MD, PhD There’s a multi-cancer early detection test available that uses a targeted methylation, next-generation sequencing-based assay to detect and analyze cell-free DNA in the bloodstream, deploy machine learning to detect a cancer signal, and predict the likely origin of the signal.2 Explore the science behind this advancement that provides the highest specificity of any cancer screening tool1 with Dr. Jennifer Caudle and Dr. Sana

en

00:00:00

Neuroplasticity: A Potential Target for the Treatment...

Medical Industry Feature ·

2023/10/10

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Madhukar H. Trivedi, MD The brain is constantly changing as a result of experience, stress, emotional processing, learning, and memory.1 And neuroplasticity adds another layer to these approaches by focusing on what’s actually changing in the brain.2 Tune in with Dr. Charles Turck as he speaks with Dr. Madhukar Trivedi, Founding Director of the Center for Depression Research and Clinical Care and Chief of the Division of Mood

en

00:00:00

Neuroplasticity: A Potential Target for the Treatment...

Medical Industry Feature ·

2023/10/10

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Madhukar H. Trivedi, MD The brain is constantly changing as a result of experience, stress, emotional processing, learning, and memory.1 And neuroplasticity adds another layer to these approaches by focusing on what’s actually changing in the brain.2 Tune in with Dr. Charles Turck as he speaks with Dr. Madhukar Trivedi, Founding Director of the Center for Depression Research and Clinical Care and Chief of the Division of Mood

en

All Episodes

Similar Podcasts

Ciência

RFI Português

天方烨谈

基因频道

Quilo de Ciencia - Cienciaes.com

Jorge Laborda

The Field Guides

The Field Guides

Down to Earth

FRANCE 24 English